FDA in Final Stage of Testing Ecstasy as a Prescription Drug

By Staff  |  11/30/2016


WTF? Apparently, Ecstasy may be legalized as a prescription drug.

According to the New York Times, the FDA (Food and Drug Administration) has received some promising results from its preliminary trials, and have given the green light to begin a large scale Phase 3 clinical trial for using Ecstasy to treat PTSD. It would be final stage before approving the drug's legal use.

The FDA has not publicly commented...

However, the news isn't out of the norm. Nonprofit organization Multidisciplinary Association for Psychedelic Studies looked into the legal medical use of drugs such as Ecstasy, LSD, and marijuana back in 1985, sponsoring Phase 2 studies for treating PTSD on a reported 130 patients. From there, it went on to fund the research for Phase 3 of the FDA, which is said to include a total of 230 patients, said the  report.

Regarding the latest trials, researchers are reportedly "optimistic", and have pushed for the FDA to speed up the approval process. "I’m cautious but hopeful," Dr. Charles R. Marmar, a leading PTSD researcher and head of psychiatry at New York University’s Langone School of Medicine, said. "If they can keep getting good results, it will be of great use. PTSD can be very hard to treat. Our best therapies right now don’t help 30 to 40 percent of people. So we need more options."

At press time, it's unclear how long the FDA's phase 3 trial would take. But if approved, Ecstasy could be hitting a pharmacies by 2021.